HIROTSU BIOSCIENCE, INC. has become a partner firm of i2.JP, launched by AstraZeneca

2022.03.11

We are pleased to announce our participation in i2.JP, an initiative launched by AstraZeneca to connect parties such as start-ups, healthcare professionals, local governments, academia and private companies. i2.JP aims to joinly solve problems in the healthcare sector and to come up with practical and optimal solutions.